CI
Income statement / Annual
Last year (2023), Cigna Corporation's total revenue was $195.19 B,
an increase of 8.05% from the previous year.
In 2023, Cigna Corporation's net income was $5.16 B.
See Cigna Corporation’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$195.19 B
|
$180.64 B
|
$174.27 B
|
$160.58 B
|
$153.74 B
|
$48.57 B
|
$42.04 B
|
$39.67 B
|
$37.88 B
|
$34.91 B
|
| Cost of Revenue |
$36.29 B |
$32.21 B |
$33.56 B |
$32.71 B |
$30.82 B |
$27.53 B |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit |
$158.90 B |
$148.44 B |
$140.71 B |
$127.87 B |
$122.92 B |
$21.04 B |
$42.04 B |
$39.67 B |
$37.88 B |
$34.91 B |
| Gross Profit Ratio |
0.81 |
0.82 |
0.81 |
0.8 |
0.8 |
0.43 |
1 |
1 |
1 |
1 |
| Research and Development
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$11.93 B
|
$9.83 B
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$14.82 B
|
$13.19 B
|
$13.03 B
|
$14.07 B
|
$14.05 B
|
$11.93 B
|
$9.83 B
|
$9.75 B
|
$0.00
|
$0.00
|
| Other Expenses |
$180.37 B |
-$139.77 B |
-$301.98 B |
-$271.58 B |
-$264.34 B |
$32.56 B |
$28.03 B |
$36.75 B |
$34.55 B |
$31.61 B |
| Operating Expenses |
$186.65 B |
$13.19 B |
-$288.95 B |
-$257.51 B |
-$250.29 B |
$44.49 B |
$37.86 B |
$36.75 B |
$34.55 B |
$31.61 B |
| Cost And Expenses |
$186.65 B |
$171.67 B |
$167.49 B |
$149.71 B |
$147.17 B |
$44.99 B |
$38.44 B |
$36.69 B |
$34.55 B |
$31.61 B |
| Interest Income |
$0.00 |
$1.30 B |
$1.30 B |
$1.40 B |
$1.60 B |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$1.45 B |
$1.23 B |
$1.21 B |
$1.44 B |
$1.68 B |
$498.00 M |
$252.00 M |
$278.00 M |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$3.03 B
|
$2.93 B
|
$2.92 B
|
$2.80 B
|
$3.65 B
|
$695.00 M
|
$566.00 M
|
$590.00 M
|
$585.00 M
|
$588.00 M
|
| EBITDA |
$9.99 B
|
$12.55 B
|
$10.91 B
|
$15.11 B
|
$11.90 B
|
$4.77 B
|
$4.42 B
|
$3.57 B
|
$3.91 B
|
$3.89 B
|
| EBITDA Ratio |
0.05 |
0.07 |
0.06 |
0.07 |
-0.6 |
0.1 |
0.11 |
0.09 |
0.1 |
0.11 |
| Operating Income Ratio
|
0.04
|
0.05
|
0.05
|
0.05
|
-0.63
|
0.08
|
0.1
|
0.08
|
0.09
|
0.09
|
| Total Other
Income/Expenses Net |
-$3.02 B
|
-$1.11 B
|
-$1.16 B
|
$2.72 B
|
-$1.51 B
|
-$579.00 M
|
-$336.00 M
|
-$109.00 M
|
-$585.00 M
|
-$31.61 B
|
| Income Before Tax |
$5.51 B |
$8.35 B |
$6.78 B |
$10.87 B |
$6.57 B |
$3.58 B |
$3.61 B |
$2.98 B |
$3.33 B |
$3.30 B |
| Income Before Tax Ratio
|
0.03
|
0.05
|
0.04
|
0.07
|
0.04
|
0.07
|
0.09
|
0.08
|
0.09
|
0.09
|
| Income Tax Expense |
$141.00 M |
$1.61 B |
$1.37 B |
$2.38 B |
$1.45 B |
$935.00 M |
$1.37 B |
$1.14 B |
$1.25 B |
$1.21 B |
| Net Income |
$5.16 B |
$6.70 B |
$5.37 B |
$8.46 B |
$5.10 B |
$2.64 B |
$2.24 B |
$1.87 B |
$2.09 B |
$2.10 B |
| Net Income Ratio |
0.03 |
0.04 |
0.03 |
0.05 |
0.03 |
0.05 |
0.05 |
0.05 |
0.06 |
0.06 |
| EPS |
17.57 |
21.66 |
15.87 |
23.17 |
13.58 |
10.69 |
9.17 |
7.31 |
8.17 |
7.97 |
| EPS Diluted |
17.39 |
21.41 |
15.73 |
22.96 |
13.44 |
10.69 |
9.17 |
7.19 |
8.04 |
7.83 |
| Weighted Average Shares
Out |
$293.89 M
|
$309.55 M
|
$337.96 M
|
$364.98 M
|
$375.92 M
|
$246.65 M
|
$243.97 M
|
$255.36 M
|
$256.15 M
|
$263.89 M
|
| Weighted Average Shares
Out Diluted |
$296.88 M
|
$313.07 M
|
$340.97 M
|
$368.39 M
|
$379.82 M
|
$246.65 M
|
$243.97 M
|
$259.65 M
|
$260.59 M
|
$268.60 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
